Global initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for chronic obstructive pulmonary disease

被引：98

作者：

Gómez, FP ^{[1
]}

Rodriguez-Roisin, R ^{[1
]}

机构：

[1] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Serv Penumol & Allergia Resp,Dept Med, E-08036 Barcelona, Spain

来源：

CURRENT OPINION IN PULMONARY MEDICINE | 2002年 / 8卷 / 02期

关键词：

D O I：

10.1097/00063198-200203000-00001

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) was developed recently to unify international efforts in the management of the disease. The most important GOLD objective is raising awareness that chronic obstructive pulmonary disease is an increasing health problem. The first step in the GOLD program was to prepare a consensus report, named "Global Strategy for the Diagnosis, Management, and Prevention of COPD," based on best-validated evidence and current pathogenetic and clinical knowledge. It encourages implementation of effective strategies for prevention, diagnosis, and management of the disease in all countries, and emphasizes the importance of renewed research initiatives. (C) 2002 Lippincott Williams Wilkins, Inc.

引用

收藏

页码：81 / 86

页数：6

相关论文

共 35 条

[1]

Altose MD, 2000, NEW ENGL J MED, V343, P1902

[2] LUNG-FUNCTION TESTING - SELECTION OF REFERENCE VALUES AND INTERPRETATIVE STRATEGIES [J].

不详 .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05) :1202-1218

[3] ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].

ANTHONISEN, NR ;

MANFREDA, J ;

WARREN, CPW ;

HERSHFIELD, ES ;

HARDING, GKM ;

NELSON, NA .

ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204

[4] EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].

ANTHONISEN, NR ;

CONNETT, JE ;

KILEY, JP ;

ALTOSE, MD ;

BAILEY, WC ;

BUIST, AS ;

CONWAY, WA ;

ENRIGHT, PL ;

KANNER, RE ;

OHARA, P ;

OWENS, GR ;

SCANLON, PD ;

TASHKIN, DP ;

WISE, RA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505

[5] Clinical guidelines for diagnosing and treating chronic obstructive pulmonary disease [J].

Barberà, JA ;

Peces-Barba, G ;

Agustí, AGN ;

Izquierdo, JL ;

Monsó, E ;

Montemayor, T ;

Viejo, JL .

ARCHIVOS DE BRONCONEUMOLOGIA, 2001, 37 (06) :297-316

[6] Exercise rehabilitation and chronic obstructive pulmonary disease stage [J].

Berry, MJ ;

Rejeski, WJ ;

Adair, NE ;

Zaccaro, D .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (04) :1248-1253

[7] Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].

Bestall, JC ;

Paul, EA ;

Garrod, R ;

Garnham, R ;

Jones, PW ;

Wedzicha, JA .

THORAX, 1999, 54 (07) :581-586

[8] Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].

Burge, PS ;

Calverley, PMA ;

Jones, PW ;

Spencer, S ;

Anderson, JA ;

Maslen, TK .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303

[9]

CELLI BR, 1999, EUR RESPIR REV, V9, P165

[10] DOSE-RESPONSE RELATION TO ORAL THEOPHYLLINE IN SEVERE CHRONIC OBSTRUCTIVE AIRWAYS DISEASE [J].

CHRYSTYN, H ;

MULLEY, BA ;

PEAKE, MD .

BRITISH MEDICAL JOURNAL, 1988, 297 (6662) :1506-1510

← 1 2 3 4 →